Table 2.
Clinicopathological characteristics of patient samples and expression of ALDH3A2 in gastric cancer
| Characteristics of ALDH3A2 | Number of cases (%) | ALDH3A2 | P.value | |
|---|---|---|---|---|
| Lowa | Highb | |||
| Age (y) | ||||
| > = 60 | 79 | 21 | 58 | 0.072 |
| < 60 | 81 | 39 | 42 | |
| Gender | ||||
| Male | 106 | 48 | 58 | 0.302 |
| Female | 34 | 12 | 22 | |
| T classification | ||||
| T1 | 12 | 7 | 5 | 0.502 |
| T2 | 26 | 10 | 16 | |
| T3 | 103 | 43 | 60 | |
| N classification | ||||
| N0 | 62 | 26 | 36 | 0.456 |
| N1 | 40 | 20 | 20 | |
| N2 | 12 | 6 | 6 | |
| N3 | 26 | 8 | 18 | |
| Grade | ||||
| Grade I | 8 | 2 | 6 | < 0.001 |
| Grade II | 48 | 11 | 32 | |
| Grade III | 68 | 43 | 25 | |
| Grade IV | 16 | 12 | 4 | |
| Clinical stage | ||||
| Stage I | 30 | 12 | 18 | 0.724 |
| Stage II | 72 | 34 | 38 | |
| Stage III | 38 | 14 | 24 | |
a scores <=6; b scores> 6